Current and future prospects of nitro-compounds as drugs for trypanosomiasis and leishmaniasis
S Patterson, AH Fairlamb - Current Medicinal Chemistry, 2019 - ingentaconnect.com
Interest in nitroheterocyclic drugs for the treatment of infectious diseases has undergone a
resurgence in recent years. Here we review the current status of monocyclic and bicyclic …
resurgence in recent years. Here we review the current status of monocyclic and bicyclic …
Discovery of novel drugs for Chagas disease: is carbonic anhydrase a target for antiprotozoal drugs?
A Beatriz Vermelho, GC Rodrigues… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Carbonic anhydrase (CA) arose significant interest as a potential new target for
Chagas disease since its discovery in Trypanosoma cruzi in 2013. Benznidazole and …
Chagas disease since its discovery in Trypanosoma cruzi in 2013. Benznidazole and …
An overview of sulfonamide‐based conjugates: Recent advances for tuberculosis treatment
Abstract In 2019, tuberculosis (TB) caused approximately 1.4 million deaths around the
world. TB is an infectious respiratory disease mainly caused by Mycobacterium tuberculosis …
world. TB is an infectious respiratory disease mainly caused by Mycobacterium tuberculosis …
The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp
CB Scarim, RC Chelucci, JL Dos Santos… - Medicinal …, 2020 - ingentaconnect.com
More than 10 million people around the world are afflicted by Neglected Tropical Diseases,
such as Chagas Disease, Human African Trypanosomiasis, and Leishmania. These …
such as Chagas Disease, Human African Trypanosomiasis, and Leishmania. These …
Recent advancement and treatment of leishmaniasis based on pharmacoinformatics approach: current and future outlook
The concept of rational treatment, target to therapy, is an old and interesting process in drug
discovery that includes the entire step from target identification to successful treatments of …
discovery that includes the entire step from target identification to successful treatments of …
Vaccine potential of HLA‐A2 epitopes from Leishmania Cysteine Protease Type III (CPC)
Although the precise host‐defence mechanisms are not completely understood, T‐cell‐
mediated immune responses are believed to play a pivotal role in controlling parasite …
mediated immune responses are believed to play a pivotal role in controlling parasite …
Immunomodulation induced through ornithine decarboxylase DNA immunization in Balb/c mice infected with Leishmania donovani
We report here a Leishmania donovani ornithine decarboxylase (Ld-ODC) gene used as a
DNA vaccine against visceral leishmaniasis in a murine Balb/c mouse model. This study …
DNA vaccine against visceral leishmaniasis in a murine Balb/c mouse model. This study …
[HTML][HTML] Noninvasive sweat-based diagnosis of visceral leishmaniasis and post kala-azar dermal leishmaniasis
RK Topno, V Shankar, MR Dikhit… - The American Journal …, 2018 - ncbi.nlm.nih.gov
The diagnosis of visceral leishmaniasis (VL) is one of the foremost barriers in the control of
this disease, as demonstration of the parasite by splenic/bone marrow aspiration is relatively …
this disease, as demonstration of the parasite by splenic/bone marrow aspiration is relatively …
Structural characterization of naphthalene sulfonamides and a sulfonate ester and their in vitro efficacy against Leishmania tarentolae promastigotes
EW Li, J Katinas, MA Jones, CG Hamaker - New Journal of Chemistry, 2021 - pubs.rsc.org
Leishmaniasis, a parasitic infectious disease transmitted by sandfly bites, is an extremely
complex human and veterinary disease. In humans, it takes different forms ranging from self …
complex human and veterinary disease. In humans, it takes different forms ranging from self …
Computational elucidation of novel antagonists and binding insights by structural and functional analyses of serine hydroxymethyltransferase and interaction with …
The crystallographic structure of the Leishmania donovani serine hydroxymethyltransferase
(Ld SHMT), an attractive target for the design of leishmanicidal agents, is still unknown …
(Ld SHMT), an attractive target for the design of leishmanicidal agents, is still unknown …